By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    PANXEON reads three signals to catch pancreatic cancer sooner
    By
    msadmin
    September 21, 2026
    One AI watchdog now covers every ward in Abu Dhabi
    By
    msadmin
    September 21, 2026
    AIIMS Delhi hands its breast screening AI to a device maker
    By
    msadmin
    September 21, 2026
    Firefly’s brain-wave AI lands inside a 27-clinic psychiatry network
    By
    msadmin
    September 21, 2026
    Medicare opens its chronic care test to AI and smart rings
    By
    msadmin
    September 21, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
    Consumer chatbots are building a medical system outside hospitals
    By
    msadmin
    August 21, 2026
    Reasoning gaps hold back AI agents in scientific discovery
    By
    msadmin
    August 11, 2026
    Benchmark scores can’t track real clinical LLM use, Stanford says
    By
    msadmin
    August 11, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

US medical boards say AI cannot hold a medical license

The Federation of State Medical Boards argues generative AI belongs inside existing physician oversight, not in a separate license.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: August 3, 2026
Share
2 Min Read
SHARE

Generative AI should not be handed its own medical license, the top two leaders of the Federation of State Medical Boards argue. In a First Opinion essay, CEO Humayun Chaudhry and board chair Christy Valentine Theard contend the technology belongs inside the oversight structures that already govern doctors, with accountability following the degree of human control.

The federation advises all 69 state and territorial boards that license physicians across the US. Its members are fielding the question more and more, as state lawmakers, pilot programs and health systems push AI deeper into clinical work and ask who answers for its decisions.

Chaudhry and Valentine Theard stress that a license carries legal and ethical weight far beyond the ability to answer questions well. It is bound to human judgment, professional conduct, transparency and a duty to put patients first, and it exists because society grants physicians exclusive privileges in exchange for accepting extraordinary responsibilities. An algorithm, they argue, cannot yet take on that compact alone.

Instead, the federation proposes governing generative AI within existing professional and institutional structures, with responsibility scaled to the system’s level of autonomy and the degree of human oversight. That keeps a clinician accountable for AI-assisted decisions while allowing the technology to expand its role over time.

The position gives state boards a clear starting point as they confront a wave of new questions: when a machine recommends a treatment, who answers for the outcome? The federation’s answer is that the physician using the tool remains the accountable party, and licensing AI as a separate practitioner would blur that line rather than clarify it.

TAGGED:AI regulationClinical AIFSMBhealth policymedical licensingstate medical boards
SOURCES:STAT News
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Innovaccer and Mastek pair up to ship agentic AI abroad

By
msadmin
August 16, 2026
News & AlertsSpotlight

UK Expands MHRA’s AI Airlock Programme With £1M Boost to Fast-Track Safe AI Medical Devices

By
Yu Chi Huang
June 23, 2025
News & Alerts

AWS becomes Novo Nordisk’s preferred AI partner for drug discovery

By
msadmin
August 10, 2026
News & Alerts

Leica Biosystems scores FDA nod for first AI pathology QC software

By
msadmin
August 12, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal